Abryl Laboratories Private Limited, a active private limited company, was established on 20 January 2016 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232CH2016PTC035904. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹36.31 Cr.
It upholds a compliant status. Employing 471 professional, Its leadership includes Vijay Kumar (Director), Jayant Singla (Director). Past directors included Deepak Gupta, Ravinder Kumar. It holds no open charges and ₹3.33 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sector-11 House No. 63, Chandigarh, Chandigarh, 160011.
U24232CH2016PTC035904
035904
20 January 2016
₹40.00 Cr
₹36.31 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Abryl Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Kumar | Director | 20 Jan 2016 | Current |
| Jayant Singla | Director | 20 Jan 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 10 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Abryl Laboratories Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 28.37% increase. The company also saw a substantial improvement in profitability, with a 230.34% increase in profit. The company's net worth moved up by a moderate rise of 0.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Abryl Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹3,327,752.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Aug 2019 | Hdfc Bank Limited | ₹1.66 M | Satisfied |
| 19 Aug 2019 | Hdfc Bank Limited | ₹1.66 M | Satisfied |
Explore comprehensive loan charge details -
Abryl Laboratories has a workforce of 471 employees as of Aug 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Abryl Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abryl Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Abryl Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Arshpreet Kaur Guliani was appointed as a Company Secretary was appointed as a Company Secretary on 15 Apr 2024 & has been associated with this company since 1 year 8 months . was completed.
The activity Abryl Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
Progress on A charge registered on 19 Aug 2019 via Charge ID 100287356 with Hdfc Bank Limited was fully satisfied on 16 Jun 2021. was documented.
A charge registered on 19 Aug 2019 via Charge ID 100287353 with Hdfc Bank Limited was fully satisfied on 16 Jun 2021. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 100287356 was registered on 19 Aug 2019. was completed.
The CIN of Abryl Laboratories Private Limited is U24232CH2016PTC035904.
Abryl Laboratories Private Limited is headquartered at Sector-11 House No. 63, Chandigarh, Chandigarh, 160011.
Abryl Laboratories Private Limited was incorporated on 20 January 2016.
The current directors of Abryl Laboratories Private Limited are
The primary industry of Abryl Laboratories Private Limited is Manufacturing.
Abryl Laboratories Private Limited is unlisted.
The authorized capital of Abryl Laboratories Private Limited is ₹40.00 Cr, and the paid-up capital is ₹36.31 Cr.
The compliance status of Abryl Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX